Identification of Functional and Expression Polymorphisms Associated With Risk for Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis

Arthritis and Rheumatology

Volumn 69, Issue 5, 2017, Pages 1054-1066

  Merkel, Peter A ^a   Xie, Gang ^b   Monach, Paul A ^c   Ji, Xuemei ^d   Ciavatta, Dominic J ^e   Byun, Jinyoung ^d   Pinder, Benjamin D ^b   Zhao, Ai ^b   Zhang, Jinyi ^f   Tadesse, Yohannes ^b   Qian, David ^d   Weirauch, Matthew ^g   Nair, Rajan ^h   Tsoi, Alex ^h   Pagnoux, Christian ⁱ   Carette, Simon ⁱ   Chung, Sharon ^j   Cuthbertson, David ^k   Davis, John C ^j   Dellaripa, Paul F ^l   Forbess, Lindsy ^m   Gewurz Singer, Ora ^h   Hoffman, Gary S ⁿ   Khalidi, Nader ^o   Koening, Curry ^p   Langford, Carol A ⁿ   Mahr, Alfred D ^q   McAlear, Carol ^a   Moreland, Larry ^r   Seo, E Philip ^s   Specks, Ulrich ^t   Spiera, Robert F ^u   Sreih, Antoine ^a   St Clair, E William ^v   Stone, John H ^w   Ytterberg, Steven R ^t   Elder, James T ^x   Qu, Jia ^y   Ochi, Toshiki ^z   Hirano, Naoto ^z   Edberg, Jeffrey C ^aa   Falk, Ronald J ^e   Amos, Christopher I ^d   Siminovitch, Katherine A ^f   more..

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b MOUNT SINAI HOSPITAL   (Canada)

^c VA BOSTON HEALTHCARE SYSTEM   (United States)

^d DARTMOUTH COLLEGE   (United States)

^e UNIVERSITY OF NORTH CAROLINA   (United States)

^f UNIVERSITY HEALTH NETWORK   (Canada)

^g CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^h UNIVERSITY OF MICHIGAN   (United States)

ⁱ UNIVERSITY OF TORONTO   (Canada)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k UNIVERSITY OF SOUTH FLORIDA   (United States)

^l BRIGHAM AND WOMEN S HOSPITAL   (United States)

^m CEDARS SINAI MEDICAL CENTER   (United States)

ⁿ LERNER RESEARCH INSTITUTE   (United States)

^o MCMASTER UNIVERSITY   (Canada)

^p UNIVERSITY OF UTAH   (United States)

^q SAINT LOUIS HOSPITAL   (France)

^r UNIVERSITY OF PITTSBURGH   (United States)

^s JOHNS HOPKINS UNIVERSITY   (United States)

^t MAYO CLINIC   (United States)

^u HOSPITAL FOR SPECIAL SURGERY   (United States)

^v DUKE UNIVERSITY MEDICAL CENTER   (United States)

^w MASSACHUSETTS GENERAL HOSPITAL   (United States)

^x VETERANS AFFAIRS MEDICAL CENTER   (United States)

^y WENZHOU MEDICAL UNIVERSITY   (China)

^z PRINCESS MARGARET HOSPITAL   (Canada)

^aa UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; HLA DP ANTIGEN; HLA DPA1 ANTIGEN; HLA DPB1 ANTIGEN; HLA DQA1 ANTIGEN; HLA DQA2 ANTIGEN; HLA DQB1 ANTIGEN; MYELOBLASTIN; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; PROTEIN; PRTN3 PROTEIN; SERPINA1 PROTEIN; UNCLASSIFIED DRUG; ALPHA 1 ANTITRYPSIN; AUTOANTIGEN; HLA-DPB1 ANTIGEN; PEROXIDASE; PTPN22 PROTEIN, HUMAN; SERPINA1 PROTEIN, HUMAN;

ALLELE; ANCA ASSOCIATED VASCULITIS; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENZYME LINKED IMMUNOSPOT ASSAY; GENE EXPRESSION; GENE LOCUS; GENOME-WIDE ASSOCIATION STUDY; HAPLOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MICROSCOPIC POLYANGIITIS; MONOCYTE; NEUTROPHIL; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE; TRANSCRIPTION INITIATION SITE; WEGENER GRANULOMATOSIS; ADULT; CASE CONTROL STUDY; FEMALE; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; ODDS RATIO;

ADULT; ALPHA 1-ANTITRYPSIN; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; AUTOANTIGENS; B-LYMPHOCYTES; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GRANULOMATOSIS WITH POLYANGIITIS; HAPLOTYPES; HLA-DP ANTIGENS; HLA-DP BETA-CHAINS; HUMANS; MALE; MICROSCOPIC POLYANGIITIS; MIDDLE AGED; MONOCYTES; MYELOBLASTIN; NEUTROPHILS; ODDS RATIO; PEROXIDASE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22; T-LYMPHOCYTES;

EID: 85017470718     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.40034     Document Type: Article

References (39)

1. Xie G, Roshandel D, Sherva R, Monach PA, Lu EY, Kung T, et al. Association of granulomatosis with polyangiitis (Wegener's) with HLA–DPB1*04 and SEMA6A gene variants: evidence from genome-wide analysis. Arthritis Rheum 2013;65:2457–68.
2. Lyons PA, Rayner TF, Trivedi S, Holle JU, Watts RA, Jayne DR, et al. Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med 2012;367:214–23.
3. Fries JF, Hunder GG, Bloch DA, Michel BA, Arend WP, Calabrese LH, et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis: summary. Arthritis Rheum 1990;33:1135–6.
4. Hoffmann TJ, Zhan Y, Kvale MN, Hesselson SE, Gollub J, Iribarren C, et al. Design and coverage of high throughput genotyping arrays optimized for individuals of East Asian, African American, and Latino race/ethnicity using imputation and a novel hybrid SNP selection algorithm. Genomics 2011;98:422–30.
5. Banda Y, Kvale MN, Hoffmann TJ, Hesselson SE, Ranatunga D, Tang H, et al. Characterizing race/ethnicity and genetic ancestry for 100,000 subjects in the Genetic Epidemiology Research on Adult Health and Aging (GERA) cohort. Genetics 2015;200:1285–95.
6. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007;81:559–75.
7. Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 2010;26:2190–1.
8. Lee SH, Wray NR, Goddard ME, Visscher PM. Estimating missing heritability for disease from genome-wide association studies. Am J Hum Genet 2011;88:294–305.
9. Howie BN, Donnelly P, Marchini J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet 2009;5:e1000529.
10. Breiman L, Friedman J, Olshen RA, Stone CJ. Classification and Regression Trees. Belmont, California: Chapman and Hall/CRC; 1984.
11. Farh KK, Marson A, Zhu J, Kleinewietfeld M, Housley WJ, Beik S, et al. Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature 2015;518:337–43.
12. Yang TP, Beazley C, Montgomery SB, Dimas AS, Gutierrez-Arcelus M, Stranger BE, et al. Genevar: a database and Java application for the analysis and visualization of SNP-gene associations in eQTL studies. Bioinformatics 2010;26:2474–6.
13. Xia K, Shabalin AA, Huang S, Madar V, Zhou YH, Wang W, et al. seeQTL: a searchable database for human eQTLs. Bioinformatics 2012;28:451–2.
14. Ct method. Methods 2001;25:402–8.
15. 1-antitrypsin deficiency–related alleles Z and S and the risk of Wegener's granulomatosis. Arthritis Rheum 2010;62:3760–7.
16. Gencik M, Meller S, Borgmann S, Fricke H. Proteinase 3 gene polymorphisms and Wegener's granulomatosis. Kidney Int 2000;58:2473–7.
17. Rarok AA, Stegeman CA, Limburg PC, Kallenberg CG. Neutrophil membrane expression of proteinase 3 (PR3) is related to relapse in PR3-ANCA-associated vasculitis. J Am Soc Nephrol 2002;13:2232–8.
18. Cho JH, Feldman M. Heterogeneity of autoimmune diseases: pathophysiologic insights from genetics and implications for new therapies. Nat Med 2015;21:730–8.
19. Carmona FD, Mackie SL, Martin JE, Taylor JC, Vaglio A, Eyre S, et al. A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility. Am J Hum Genet 2015;96:565–80.
20. Jagiello P, Aries P, Arning L, Wagenleiter SE, Csernok E, Hellmich B, et al. The PTPN22 620W allele is a risk factor for Wegener's granulomatosis. Arthritis Rheum 2005;52:4039–43.
21. Chung SA, Xie G, Roshandel D, Sherva R, Edberg JC, Kravitz M, et al. Meta-analysis of genetic polymorphisms in granulomatosis with polyangiitis (Wegener's) reveals shared susceptibility loci with rheumatoid arthritis. Arthritis Rheum 2012;64:3463–71.
22. Diaz G, Amicosante M, Jaraquemada D, Butler RH, Guillen MV, Sanchez M, et al. Functional analysis of HLA-DP polymorphism: a crucial role for DPβ residues 9, 11, 35, 55, 56, 69 and 84-87 in T cell allorecognition and peptide binding. Int Immunol 2003;15:565–76.
23. Zhang J, Zahir N, Jiang Q, Miliotis H, Heyraud S, Meng X, et al. The autoimmune disease-associated PTPN22 variant promotes calpain-mediated Lyp/Pep degradation associated with lymphocyte and dendritic cell hyperresponsiveness. Nat Genet 2011;43:902–7.
24. The GTEx Consortium. The Genotype-Tissue Expression (GTEx) project. Nat Genet 2013;45:580–5.
25. Yang JJ, Pendergraft WF, Alcorta DA, Nachman PH, Hogan SL, Thomas RP, et al. Circumvention of normal constraints on granule protein gene expression in peripheral blood neutrophils and monocytes of patients with antineutrophil cytoplasmic autoantibody-associated glomerulonephritis. J Am Soc Nephrol 2004;15:2103–14.
26. Doytchinova IA, Flower DR. In silico identification of supertypes for class II MHCs. J Immunol 2005;174:7085–95.
27. Silveira LJ, McCanlies EC, Fingerlin TE, van Dyke MV, Mroz MM, Strand M, et al. Chronic beryllium disease, HLA-DPB1, and the DP peptide binding groove. J Immunol 2012;189:4014–23.
28. Thomas R, Thio CL, Apps R, Qi Y, Gao X, Marti D, et al. A novel variant marking HLA-DP expression levels predicts recovery from hepatitis B virus infection. J Virol 2012;86:6979–85.
29. Petersdorf EW, Malkki M, O'hUigin C, Carrington M, Gooley T, Haagenson MD, et al. High HLA-DP expression and graft-versus-host disease. N Engl J Med 2015;373:599–609.
30. Van der Geld YM, Huitema MG, Franssen CF, van der Zee R, Limburg PC, Kallenberg CG. In vitro T lymphocyte responses to proteinase 3 (PR3) and linear peptides of PR3 in patients with Wegener's granulomatosis (WG). Clin Exp Immunol 2000;122:504–13.
31. Winek J, Mueller A, Csernok E, Gross WL, Lamprecht P. Frequency of proteinase 3 (PR3)-specific autoreactive T cells determined by cytokine flow cytometry in Wegener's granulomatosis. J Autoimmun 2004;22:79–85.
32. Popa ER, Franssen CF, Limburg PC, Huitema MG, Kallenberg CG, Tervaert JW. In vitro cytokine production and proliferation of T cells from patients with anti–proteinase 3– and antimyeloperoxidase-associated vasculitis, in response to proteinase 3 and myeloperoxidase. Arthritis Rheum 2002;46:1894–904.
33. Pendergraft WF III, Preston GA, Shah RR, Tropsha A, Carter CW Jr, Jennette JC, et al. Autoimmunity is triggered by cPR-3(105–201), a protein complementary to human autoantigen proteinase-3. Nat Med 2004;10:72–9.
34. Csernok E, Ai M, Gross WL, Wicklein D, Petersen A, Lindner B, et al. Wegener autoantigen induces maturation of dendritic cells and licenses them for Th1 priming via the protease-activated receptor-2 pathway. Blood 2006;107:4440–8.
35. Yang J, Bautz DJ, Lionaki S, Hogan SL, Chin H, Tisch RM, et al. ANCA patients have T cells responsive to complementary PR-3 antigen. Kidney Int 2008;74:1159–69.
36. Chen GB, Lee SH, Brion MJ, Montgomery GW, Wray NR, Radford-Smith GL, et al. Estimation and partitioning of (co)heritability of inflammatory bowel disease from GWAS and immunochip data. Hum Mol Genet 2014;23:4710–20.
37. Duranton J, Bieth JG. Inhibition of proteinase 3 by α1-antitrypsin in vitro predicts very fast inhibition in vivo. Am J Respir Cell Mol Biol 2003;29:57–61.
38. Ciavatta DJ, Yang J, Preston GA, Badhwar AK, Xiao H, Hewins P, et al. Epigenetic basis for aberrant upregulation of autoantigen genes in humans with ANCA vasculitis. J Clin Invest 2010;120:3209–19.
39. Kelley JM, Monach PA, Ji C, Zhou Y, Wu J, Tanaka S, et al. IgA and IgG antineutrophil cytoplasmic antibody engagement of Fc receptor genetic variants influences granulomatosis with polyangiitis. Proc Natl Acad Sci U S A 2011;108:20736–41.